January 31, 2008 10:00AM Eastern Daylight Time
Azopharma Product Development Group Acquires Clinical Site, Coastal Medical Research Inc., in Daytona Beach, FL
MIRAMAR, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) is pleased to announce the acquisition of Coastal Medical Research, Inc. (CMR), a clinical pharmacology facility located in Daytona Beach, FL which will operate under the AvivoClin name. AvivoClin Clinical Services, which was unveiled at the 2007 AAPS Meeting and Exposition, is the clinical pharmacology division of the Azopharma Product Development Group.
The facility will provide phase I-III clinical services across all major therapeutic areas. When asked about the acquisition Phil Meeks stated, “We are truly excited about expanding our clinical pharmacology services. Not only does this expand the capabilities of AvivoClin it allows the Azopharma Product Development Group to more completely serve companies seeking full product development.”
The CMR facility includes 48 beds and 15,000 sq. ft. of space. Azopharma plans to expand the CMR facility to house over 100 beds. Phil Meeks adds, “We believe we will provide added benefit to CMR’s current clients not only through our investment in the facilities and infrastructure, but by providing services critical to support clinical studies such as formulation, CTM manufacturing, and bioanalytical testing.”
Located in Daytona Beach, the facility is strategically located to recruit patients from local universities and colleges. The facility is also strategically placed to recruit specialty patient populations such as senior citizens from the areas many retirement communities.
Azopharma Product Development Group Includes:
- Azopharma Contract Pharmaceutical Services - Integrated product development and CTM manufacturing for all dosage forms.
- ApiCross Drug Delivery Technologies - Proprietary drug delivery platforms to solve difficult molecular challenges.
- Cyanta Analytical Laboratories - Analytical chemistry and inhalation services from development to quality control testing.
- AniClin Preclinical Services - Preclinical services in support of early product development.
- IQsynthesis - Synthetic chemistry services from discovery to clinical API supplies including large scale API synthesis.
- AvivoClin Clinical Services - Human clinical pharmacology services for Phase I/II/III clinical trials.
About Azopharma
Azopharma Product Development Group is FDA registered, DEA approved and client audited on a regular basis. Azopharma’s mission is to help our customers turn Ideas Into Cures™. In product development, it comes down to the right people, their commitment and application of experience. Partnering with Azopharma provides customers with the confidence of assured success. We welcome visits to our facility in Miramar, FL and our other sites to conduct audits or meet with our pharmaceutical scientists to outline a study that meets your specific needs. Contact us at development@azopharma.com or 954-433-7480.
Contact
Phil Meeks, CEO
Azopharma Product Development Group
10320 USA Today Way
Miramar FL 33025
Phone: 954-433-7480
www.azopdogroup.com